Bioabsorbable Stents Market is Likely to Witness Steady Growth by 2032

Posted by Ganesh Shinde on March 16th, 2023

The global bioabsorbable stents market is expected to grow from US$ 159.6 million in 2021 to US$ 248.5 million by 2032, at a CAGR of 4.2%. A recent study reveals that in 2021, coronary artery stents will account for approximately 76.3% of the global bioabsorbable stents market.

Unlike regular stents, bioabsorbable stents are made from materials that are easily absorbed by the body, and function similarly to regular medical stents. The market for bioabsorbable stents is anticipated to be worth US$ 165.4 million by the end of 2022, and is poised to reach a value of around US$ 350 million by the same year.

Bioabsorbable polymeric stents have gained popularity due to their ability to treat coronary artery disease (CAD) without producing long-term complications. The study shows that biodegradable polymers and copolymers are the preferred materials for bioabsorbable stents, and have undergone significant improvements in material processing, mechanical performance, and biodegradability.

Key Players Included in the Bioabsorbable Stents Market:

• Boston Scientific Corporation
• Meril Life Sciences Pvt. Ltd.
• Medtronic Plc
• Smith & Nephew Plc
• Stryker Corporation
• Wright Medical Group
• KLS Martin
• BIOTRONIK Ltd
• Syntellix AG
• Q3 Medical Devices Limited.
• JW Medical Systems LTD
• ORBUSNEICH MEDICAL
• Abbott Vascular

Get More Details@ https://www.futuremarketinsights.com/reports/bioabsorbable-stents-market

Key Market Segments Covered in Bioabsorbable Stents Industry Research

By Stents:

• Coronary Artery Stents
• Peripheral Artery Stents
• Non-vascular Stents
  • Esophageal Stents
  • Billary Stents

By Material:

• Metallic
• Ceramic
• Polymers
  • PGA
  • PLA
  • Co-Polymer

By Application:

• Cardiovascular
• Orthopedics
• Cosmetic Surgery
• General Surgery
• Cranial
• Others

By End User:

• Hospitals
• Speciality Clinics
• Ambulatory surgical Centers